| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.27 | 0.1 |